Who Exports Omega from India — 134 Suppliers Behind a $18.9M Market
India's omega export market is supplied by 134 active exporters who collectively shipped $18.9M across 604 shipments. STRIDES PHARMA SCIENCE LIMITED leads with a 53.9% market share, followed by MANKIND PHARMA LIMITED and MACLEODS PHARMACEUTICALS LTD. The top 5 suppliers together control 83.9% of total export value, reflecting a concentrated market structure.
Top Omega Exporters from India — Ranked by Export Value
STRIDES PHARMA SCIENCE LIMITED is the leading omega exporter from India, holding a 53.9% share of the $18.9M market across 604 shipments from 134 exporters. The top 5 suppliers — STRIDES PHARMA SCIENCE LIMITED, MANKIND PHARMA LIMITED, MACLEODS PHARMACEUTICALS LTD, OLIVE HEALTH CARE, SAGA LIFESCIENCES LIMITED — collectively control 83.9% of total export value, indicating a highly concentrated market. Individual shares are: STRIDES PHARMA SCIENCE LIMITED (53.9%), MANKIND PHARMA LIMITED (20.0%), MACLEODS PHARMACEUTICALS LTD (5.5%), OLIVE HEALTH CARE (2.3%), SAGA LIFESCIENCES LIMITED (2.2%).
Top Omega Exporters from India
Ranked by export value · 134 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | STRIDES PHARMA SCIENCE LIMITED OMEGA3ACID ETHYL ESTER 1G 120 S US SPI PACK SIZE 32976X120SOMEGA-3-ACID ETHYL ESTERS CAPSULES [1G][SOFT GELATIN]TRIOMECOR 1X28`S | $10.2M | 4 | 53.9% |
| 2 | MANKIND PHARMA LIMITED OMEGA3ACID ETHYL ESTER 1G 120 S US SPI PACK SIZE 32976X120STRIOMECOR 1X28`STRIOMECOR OMEGA 3 FISH OIL 1X28 S | $3.8M | 1 | 20.0% |
| 3 | MACLEODS PHARMACEUTICALS LTD | $1.0M | 3 | 5.5% |
| 4 | OLIVE HEALTH CARE PHARMACEUTICAL PRODUCTS DARAVIT OMEGACLARION MAX OMEGA CAPSULES (FISH OIL CAPOMEGA-3 + DAILYVIT CAPSULES COMBI PACK O | $429.9K | 5 | 2.3% |
| 5 | SAGA LIFESCIENCES LIMITED | $406.5K | 3 | 2.2% |
| 6 | SOFTGEL HEALTHCARE PRIVATE LIMITED PHARMACEUTICAL PRODUCTS DARAVIT OMEGACLARION MAX OMEGA CAPSULES (FISH OIL CAPOMEGA-3 + DAILYVIT CAPSULES COMBI PACK O | $316.3K | 2 | 1.7% |
| 7 | CAPLIN POINT LABORATORIES LIMITED OMEGA-3 ACID ETHYL ESTER CAPSULES USP 1000MGNOSOMEGA-3 ACID ETHYL ESTER CAPSULES USP 10OMEGA-3 ACID ETHYL ESTER CAPSULES USP 500MGNOS | $303.3K | 1 | 1.6% |
| 8 | NUCREST PHARMA PRIVATE LIMITED PHARMACEUTICAL PRODUCTS DARAVIT OMEGACLARION MAX OMEGA CAPSULES (FISH OIL CAPOMEGA-3 + DAILYVIT CAPSULES COMBI PACK O | $199.0K | 2 | 1.1% |
| 9 | CIPLA LIMITED OMEGAPHARM NYSTATIN ORAL DROPS WITH DROPPEROMEGAPHARM NYSTATIN ORAL DROPS WITH DROPMITOMYCIN OMEGAPHARM 2MG | $144.7K | 1 | 0.8% |
| 10 | OXFORD LABORATORIES PRIVATE LIMITED | $134.0K | 5 | 0.7% |
| 11 | RENOWN PHARMACEUTICALS PRIVATE LIMITED PHARMACEUTICAL PRODUCTS DARAVIT OMEGACLARION MAX OMEGA CAPSULES (FISH OIL CAPOMEGA-3 + DAILYVIT CAPSULES COMBI PACK O | $104.9K | 1 | 0.6% |
| 12 | ASOJ SOFT CAPS PVT LTD PHARMACEUTICAL PRODUCTS DARAVIT OMEGACLARION MAX OMEGA CAPSULES (FISH OIL CAPOMEGA-3 + DAILYVIT CAPSULES COMBI PACK O | $89.2K | 5 | 0.5% |
| 13 | SERAGA LIFESCIENCES PRIVATE LIMITED | $71.1K | 1 | 0.4% |
| 14 | UMEDICA LABORATORIES PRIVATE LIMITED | $65.5K | 2 | 0.3% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Omega exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Cipla Limited | Warning Letter (November | Yes (May 2009) | Unknown | Unknown | Received FDA warning letter in November 2023 for Indore facility; WHO-GMP certif |
| Strides Pharma Science Limited | Approved | Yes (October 2010) | Unknown | Unknown | WHO-GMP certified in October 2010; no FDA warning letters found. |
| Macleods Pharmaceuticals Ltd | Approved | Yes (December 2016) | Unknown | Unknown | WHO-GMP certified in December 2016; no FDA warning letters found. |
| Mankind Pharma Limited | Approved | Yes (November 2025) | Unknown | Unknown | WHO-GMP certification valid until November 2025; no FDA warning letters found. |
| Umedica Laboratories Private Limited | Approved | Unknown | Unknown | Unknown | FDA filings for multiple prescription medications; no FDA warning letters found. |
TransData Nexus reviewed the regulatory standing of 5 leading Omega exporters from India. 4 hold US FDA facility approvals, 4 maintain WHO-GMP certification, and 0 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Omega sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Pharma City of India," is a pivotal hub for pharmaceutical manufacturing and research. The city contributes approximately 40% of India's bulk drug production and houses over 2,000 pharmaceutical companies. Notably, Hyderabad Pharma City is an ambitious project aiming to create the world's largest integrated pharmaceutical ecosystem, encompassing manufacturing, R&D, and sustainable living environments. This robust infrastructure and concentration of expertise make Hyderabad a strategic location for sourcing bulk drugs like "Omega."
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports, with Ahmedabad and Vadodara being central to this output. The region hosts major companies such as Alembic Pharmaceuticals, Sun Pharma, and Cadila Pharmaceuticals. Vadodara, in particular, is home to Alembic Pharmaceuticals, one of India's oldest pharmaceutical companies, established in 1907. This concentration of formulation expertise positions the region as a key player in the production and export of pharmaceutical products like "Omega."
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical industry. Mumbai, being a major port city, facilitates substantial pharmaceutical exports, including products like "Omega." The region's well-established logistics and proximity to international shipping routes enhance its role in the global pharmaceutical supply chain.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh is recognized for its tax incentives, attracting numerous pharmaceutical manufacturers. The region offers benefits such as excise duty exemptions and income tax holidays, making it an attractive location for production. This has led to the establishment of various manufacturing units, contributing to the overall pharmaceutical output, including products like "Omega."
5Sourcing Recommendations
- Diversify Supplier Base: While Strides Pharma Science Limited is the leading supplier of "Omega," consider engaging with other top suppliers like Mankind Pharma Limited and Macleods Pharmaceuticals Ltd. to mitigate supply chain risks.
- Leverage Regional Strengths: Utilize Hyderabad for bulk drug sourcing due to its extensive manufacturing capabilities, and Ahmedabad-Vadodara for formulations, capitalizing on their specialized expertise.
- Optimize Logistics: Utilize the Mumbai-Thane-Raigad region's export infrastructure to streamline shipping processes and reduce lead times for international deliveries.
- Explore Incentive Zones: Assess the benefits of manufacturing in tax incentive zones like Baddi-Nalagarh to potentially reduce production costs and enhance profitability.
By strategically engaging with these pharmaceutical clusters, TransData Nexus can enhance its sourcing efficiency and strengthen its position in the global pharmaceutical market.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Omega exporters from India
Strides Pharma Science Limited — Strides announces creation of OneSource Specialty Pharma
Strides Pharma Science Limited approved a Scheme of Arrangement to establish OneSource Specialty Pharma, integrating its Soft Gelatin Capsules CDMO business with Steriscience's complex injectables and Stelis Biopharma's biologics CDMO businesses. This consolidation aims to create a comprehensive specialty pharma CDMO platform. - IMPACT: The formation of OneSource is expected to enhance Strides' manufacturing capabilities, potentially increasing Omega product exports.
Impact: The formation of OneSource is expected to enhance Strides' manufacturing capabilities, potentially increasing Omega product exports.
Strides Pharma Science Limited — Strides secures shareholder and creditor approval for OneSource creation
Strides Pharma Science Limited received overwhelming approval from its equity shareholders and secured creditors for the creation of OneSource Specialty Pharma. This approval marks a significant step towards establishing India's first specialty pharma CDMO. - IMPACT: The approval facilitates the operationalization of OneSource, which may lead to increased Omega product exports.
Impact: The approval facilitates the operationalization of OneSource, which may lead to increased Omega product exports.
Strides Pharma Science Limited — OneSource secures ₹801 crore from investors ahead of listing
OneSource Specialty Pharma, the CDMO arm of Strides Pharma Science Limited, received confirmed capital infusion commitments totaling ₹801 crore from domestic and foreign institutional investors in a pre-listing funding round. This investment is intended to accelerate growth plans and expand manufacturing capacities. - IMPACT: The additional funding is likely to enhance production capabilities, potentially boosting Omega product exports.
Impact: The additional funding is likely to enhance production capabilities, potentially boosting Omega product exports.
Common Questions — Omega Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which omega supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, STRIDES PHARMA SCIENCE LIMITED leads with 53 recorded shipments worth $10.2M. MANKIND PHARMA LIMITED (84 shipments) and MACLEODS PHARMACEUTICALS LTD (3 shipments) are also established high-volume exporters.
Q How many omega manufacturers are there in India?
India has 134 active omega exporters with a combined export market of $18.9M across 604 shipments to 82 countries. The top 5 suppliers hold 83.9% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for omega from India?
Average FOB unit price: $4.14 per unit, ranging from $0.00 to $126.49. Average shipment value: $31.3K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 134 verified Indian exporters of Omega ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 604 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 82 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
604 Verified Shipments
134 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists